QDEL · QuidelOrtho Corp
$15.32
+0.41 (+2.75%)
At close · Aug 27
Market Cap
$1.02B
Shares
68.58M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Brian Blaser | CEO | $11,255,782 |
| Brian J. Blaser | President and CEO | $11,255,782 |
| Joseph M. Busky | CFO | $5,355,620 |
| Michelle A. Hodges | Former CLO | $3,508,070 |
| Philip D. McLellan | COO | $2,021,992 |
| Jonathan P. Siegrist | EVP of R&D and CTO | $1,791,096 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Brian Blaser | CEO | $15,044,937 |
| Brian J. Blaser | President and CEO | $15,044,937 |
| Douglas C. Bryant | Former President and CEO | $12,050,065 |
| Robert J. Bujarski | Former Interim President, EVP and COO | $6,438,477 |
| Michael S. Iskra | Former Interim CEO, EVP and CCO | $6,191,573 |
| Joseph M. Busky | CFO | $4,699,610 |
| Michelle A. Hodges | CLO | $3,311,100 |
| Jonathan P. Siegrist | EVP of R&D and CTO | $2,724,630 |
| Patrick E. Klein | Former SVP, CAO | $2,543,141 |
| Philip D. McLellan | COO | $1,622,222 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Douglas C. Bryant | Former President and CEO | $6,757,143 |
| Robert J. Bujarski | Former Interim President, EVP and COO | $3,409,686 |
| Michael S. Iskra | Former Interim CEO, EVP and CCO | $3,319,354 |
| Joseph M. Busky | CFO | $2,943,018 |
| Werner Kroll | SVP, Research and Development | $2,026,616 |
| Michelle A. Hodges | CLO | $1,800,485 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Douglas C. Bryant | Former President and CEO | $12,885,604 |
| Robert J. Bujarski | Former Interim President, EVP and COO | $6,051,941 |
| Michelle A. Hodges | CLO | $3,545,805 |
| Joseph M. Busky | CFO | $3,255,396 |
| Randall J. Steward | — | $3,157,747 |
| Werner Kroll | SVP, Research and Development | $3,101,095 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Douglas C. Bryant | Former President and CEO | $5,464,148 |
| Michelle A. Hodges | SVP, General Counsel | $3,241,432 |
| Robert J. Bujarski | Interim President, EVP and COO | $2,351,466 |
| Werner Kroll | SVP, Research and Development | $2,258,221 |
| Former CFO | — | $2,056,415 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Douglas C. Bryant | President and CEO | $7,177,709 |
| Former CFO | — | $2,513,523 |
| Werner Kroll | SVP, Research and Development | $2,509,994 |
| Robert J. Bujarski | EVP and Chief Operating Officer | $2,244,146 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Micah Young | Chief Financial Officer and principal financial officer | Appointed | 2026-06-23 |
| Nathaniel "Nate" Sisitsky | Chief Legal Officer | Appointed | 2026-03-24 |
| Michelle A. Hodges | Chief Legal Officer and Corporate Secretary | Retired | 2026-03-24 |
| Joseph M. Busky | Chief Financial Officer and principal financial officer | Retired | 2026-02-13 |
| Joseph D. Wilkins Jr. | director | Appointed | 2025-05-27 |
| Kenneth J. Widder, M.D. | director | Appointed | 2025-05-27 |
| Ann D. Rhoads | director | Appointed | 2025-05-27 |
| Matthew W. Strobeck, Ph.D. | director | Appointed | 2025-05-27 |
| Edward L. Michael | director | Appointed | 2025-05-27 |
| Mary Lake Polan, M.D., Ph.D., M.P.H. | director | Appointed | 2025-05-27 |
| R. Scott Huennekens | director | Appointed | 2025-05-27 |
| Evelyn S. Dilsaver | director | Appointed | 2025-05-27 |
| John R. Chiminski | director | Appointed | 2025-05-27 |
| Kenneth F. Buechler, Ph.D. | director | Appointed | 2025-05-27 |
| Brian J. Blaser | director | Appointed | 2025-05-27 |
| James R. Prutow | Board | Resigned | 2024-12-10 |
| Robert R. Schmidt | Board | Resigned | 2024-12-10 |
| R. Scott Huennekens | director | Appointed | 2024-12-10 |
| John R. Chiminski | director | Appointed | 2024-12-10 |
| Robert R. Schmidt | member of the Company's Board of Directors | Resigned | 2024-11-21 |
| James R. Prutow | member of the Company's Board of Directors | Resigned | 2024-11-21 |
| Philip McLellan | Chief Operations Officer | Appointed | 2024-11-08 |
| Robert J. Bujarski | Executive Vice President and Chief Operating Officer | Terminated | 2024-11-08 |
| Michael S. Iskra | Executive Vice President and Chief Commercial Officer | Terminated | 2024-11-08 |
| Brian J. Blaser | director | Appointed | 2024-05-07 |
Key facts
CIK
1906324
CUSIP
219798105
13F (30d)
200 filings
196 filers
Visit website
Investor relations